Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 26 | 2026 | 1019 | 3.680 |
Why?
|
| Cognitive Dysfunction | 15 | 2026 | 271 | 2.620 |
Why?
|
| Blood-Brain Barrier | 5 | 2026 | 97 | 1.910 |
Why?
|
| Sympathetic Nervous System | 4 | 2024 | 68 | 1.900 |
Why?
|
| Neurovascular Coupling | 9 | 2022 | 154 | 1.700 |
Why?
|
| Cellular Senescence | 11 | 2026 | 141 | 1.670 |
Why?
|
| Endothelium, Vascular | 11 | 2026 | 334 | 1.650 |
Why?
|
| Obesity | 7 | 2024 | 702 | 1.630 |
Why?
|
| Oxidative Stress | 12 | 2026 | 678 | 1.370 |
Why?
|
| Cognition | 6 | 2025 | 331 | 1.220 |
Why?
|
| Dementia, Vascular | 5 | 2026 | 57 | 1.190 |
Why?
|
| Endothelial Cells | 6 | 2026 | 373 | 1.160 |
Why?
|
| Transcriptome | 3 | 2026 | 232 | 1.160 |
Why?
|
| Brain Stem | 3 | 2024 | 23 | 1.070 |
Why?
|
| NF-E2-Related Factor 2 | 4 | 2024 | 122 | 1.040 |
Why?
|
| Inflammation | 8 | 2026 | 668 | 0.990 |
Why?
|
| Mice, Inbred C57BL | 19 | 2026 | 1661 | 0.980 |
Why?
|
| Adipose Tissue, Beige | 1 | 2026 | 8 | 0.970 |
Why?
|
| Adipose Tissue, White | 1 | 2026 | 24 | 0.960 |
Why?
|
| Brain | 9 | 2026 | 770 | 0.950 |
Why?
|
| Animals | 34 | 2026 | 10715 | 0.930 |
Why?
|
| Energy Metabolism | 2 | 2026 | 216 | 0.880 |
Why?
|
| Lipid Metabolism | 1 | 2026 | 152 | 0.850 |
Why?
|
| Adipose Tissue | 1 | 2026 | 197 | 0.850 |
Why?
|
| Microvessels | 3 | 2021 | 86 | 0.840 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 18 | 0.830 |
Why?
|
| Vascular Stiffness | 2 | 2019 | 41 | 0.730 |
Why?
|
| Neuroglia | 1 | 2021 | 30 | 0.690 |
Why?
|
| Mice | 18 | 2026 | 4815 | 0.670 |
Why?
|
| Cerebrovascular Circulation | 7 | 2022 | 225 | 0.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 344 | 0.630 |
Why?
|
| Arterial Pressure | 1 | 2019 | 9 | 0.630 |
Why?
|
| Rejuvenation | 5 | 2026 | 33 | 0.630 |
Why?
|
| Medulla Oblongata | 1 | 2019 | 12 | 0.620 |
Why?
|
| Cardiovascular System | 1 | 2019 | 41 | 0.610 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2019 | 3 | 0.610 |
Why?
|
| Heart Rate | 2 | 2020 | 382 | 0.580 |
Why?
|
| Astrocytes | 4 | 2024 | 80 | 0.530 |
Why?
|
| Hypertension | 1 | 2018 | 309 | 0.480 |
Why?
|
| Nicotinamide Mononucleotide | 3 | 2020 | 23 | 0.460 |
Why?
|
| Male | 14 | 2026 | 13983 | 0.450 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 381 | 0.430 |
Why?
|
| Mitochondria | 4 | 2026 | 410 | 0.420 |
Why?
|
| NAD | 3 | 2025 | 104 | 0.390 |
Why?
|
| Vasodilation | 3 | 2024 | 115 | 0.380 |
Why?
|
| Biomarkers | 4 | 2024 | 782 | 0.360 |
Why?
|
| Microcirculation | 3 | 2020 | 113 | 0.350 |
Why?
|
| Aorta | 2 | 2024 | 124 | 0.340 |
Why?
|
| Dietary Supplements | 3 | 2025 | 273 | 0.340 |
Why?
|
| Peripheral Arterial Disease | 2 | 2025 | 144 | 0.340 |
Why?
|
| Diet, High-Fat | 2 | 2024 | 144 | 0.340 |
Why?
|
| Parabiosis | 2 | 2022 | 17 | 0.340 |
Why?
|
| Humans | 22 | 2026 | 28998 | 0.330 |
Why?
|
| Hyperemia | 2 | 2021 | 40 | 0.320 |
Why?
|
| Aged | 9 | 2025 | 5608 | 0.320 |
Why?
|
| Cognitive Aging | 2 | 2020 | 22 | 0.310 |
Why?
|
| Cytokines | 3 | 2020 | 452 | 0.300 |
Why?
|
| Cerebrovascular Disorders | 2 | 2020 | 46 | 0.300 |
Why?
|
| Disease Models, Animal | 8 | 2023 | 1511 | 0.290 |
Why?
|
| Vascular Diseases | 2 | 2019 | 68 | 0.280 |
Why?
|
| Age Factors | 5 | 2021 | 740 | 0.270 |
Why?
|
| Microglia | 2 | 2026 | 69 | 0.260 |
Why?
|
| Risk Factors | 3 | 2020 | 2134 | 0.250 |
Why?
|
| Uncoupling Protein 1 | 1 | 2026 | 22 | 0.240 |
Why?
|
| Adipose Tissue, Brown | 1 | 2026 | 22 | 0.240 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2026 | 10 | 0.240 |
Why?
|
| Lipoproteins, LDL | 1 | 2026 | 42 | 0.240 |
Why?
|
| Fibrosis | 1 | 2026 | 143 | 0.230 |
Why?
|
| Fasting | 1 | 2026 | 91 | 0.230 |
Why?
|
| Oxygen Consumption | 1 | 2026 | 190 | 0.230 |
Why?
|
| Niacinamide | 1 | 2025 | 32 | 0.220 |
Why?
|
| Palmitic Acid | 1 | 2024 | 11 | 0.220 |
Why?
|
| Glioblastoma | 1 | 2026 | 109 | 0.220 |
Why?
|
| Down-Regulation | 1 | 2024 | 202 | 0.210 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 136 | 0.200 |
Why?
|
| Macrophages | 1 | 2026 | 306 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2021 | 75 | 0.190 |
Why?
|
| Disease Progression | 2 | 2023 | 479 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 292 | 0.190 |
Why?
|
| Brain Neoplasms | 1 | 2026 | 313 | 0.190 |
Why?
|
| Aging, Premature | 1 | 2022 | 3 | 0.190 |
Why?
|
| Dementia | 1 | 2023 | 97 | 0.180 |
Why?
|
| Antioxidants | 2 | 2020 | 224 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2022 | 44 | 0.180 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 28 | 0.180 |
Why?
|
| Aniline Compounds | 1 | 2021 | 23 | 0.170 |
Why?
|
| Norepinephrine | 1 | 2021 | 32 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2020 | 631 | 0.170 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 41 | 0.170 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2021 | 8 | 0.170 |
Why?
|
| Intravital Microscopy | 1 | 2021 | 10 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 90 | 0.170 |
Why?
|
| Microvascular Rarefaction | 1 | 2021 | 13 | 0.170 |
Why?
|
| Sulfonamides | 1 | 2021 | 73 | 0.170 |
Why?
|
| Prosencephalon | 1 | 2020 | 7 | 0.170 |
Why?
|
| Hippocampus | 2 | 2019 | 198 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2021 | 221 | 0.170 |
Why?
|
| Capillary Permeability | 1 | 2021 | 56 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2021 | 191 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 96 | 0.160 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 40 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 58 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 41 | 0.160 |
Why?
|
| Phenanthrenes | 1 | 2019 | 10 | 0.160 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2020 | 76 | 0.150 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 71 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 49 | 0.150 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 15 | 0.150 |
Why?
|
| Cerebral Veins | 1 | 2019 | 11 | 0.150 |
Why?
|
| Eicosanoids | 1 | 2019 | 10 | 0.150 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 38 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 48 | 0.150 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 18 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2021 | 668 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2020 | 186 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 51 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 64 | 0.140 |
Why?
|
| Liposomes | 1 | 2019 | 145 | 0.140 |
Why?
|
| Leptin | 1 | 2018 | 67 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 169 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 124 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 152 | 0.140 |
Why?
|
| Female | 6 | 2025 | 15690 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2019 | 303 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2023 | 249 | 0.080 |
Why?
|
| Phenotype | 2 | 2022 | 687 | 0.080 |
Why?
|
| Neurons | 2 | 2021 | 297 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2023 | 1283 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2026 | 56 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 191 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2026 | 381 | 0.050 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2024 | 4 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2026 | 195 | 0.050 |
Why?
|
| Aldehydes | 1 | 2024 | 55 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 464 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 55 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2019 | 1470 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 200 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 41 | 0.050 |
Why?
|
| Arterioles | 1 | 2022 | 61 | 0.050 |
Why?
|
| Gray Matter | 1 | 2022 | 24 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 430 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 11 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2024 | 1022 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 205 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2021 | 35 | 0.040 |
Why?
|
| Reaction Time | 1 | 2021 | 95 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 68 | 0.040 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2020 | 12 | 0.040 |
Why?
|
| Middle Aged | 2 | 2025 | 7428 | 0.040 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 16 | 0.040 |
Why?
|
| Microdissection | 1 | 2020 | 15 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 28 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2020 | 106 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 2067 | 0.040 |
Why?
|
| Spatial Learning | 1 | 2019 | 6 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2020 | 52 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 739 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 74 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2019 | 50 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 64 | 0.040 |
Why?
|
| Rodentia | 1 | 2019 | 14 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2019 | 72 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2019 | 174 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 128 | 0.040 |
Why?
|
| Geriatrics | 1 | 2019 | 47 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 81 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 148 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2019 | 153 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 145 | 0.040 |
Why?
|
| Diet | 1 | 2020 | 241 | 0.040 |
Why?
|
| Research | 1 | 2019 | 93 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2019 | 97 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2019 | 207 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 8048 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 148 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 272 | 0.030 |
Why?
|
| Longevity | 1 | 2019 | 141 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 485 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 554 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 470 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 376 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 466 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1592 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 1619 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 898 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 825 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 876 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 523 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 843 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 2842 | 0.030 |
Why?
|
| United States | 1 | 2020 | 2247 | 0.030 |
Why?
|
Balasubramanian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(56)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_